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(57) ABSTRACT
This invention relates to plants having modified reproduc­
tive capacity. In particular, it relates to a plant reproductive 
tissue specific promoter, the PrAGl promoter isolated from 
Pinus radiata, and its use in promoting transcription/ 
expression of associated sequences in plant reproductive 
tissue, including for the purpose of producing plants which 
have diminished reproductive capacity or which are sterile.
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TGT GTA CAA ATC ATG GGT CGT GGG AAG ATT GAG ATA AAG AGG ATT GAA AAT ACT 54
M G R G K I E I K R I E N T
ACG AAC CGA CAG GTC ACT TTC TGC AAG CGC CGA AAT GGT TTA TTA AAG AAG GCG 108
T N R Q V T F c K R R N G L L K K A
TAT GAA TTA TCA GTT CTT TGT GAT GCA GAA GTG GCC CTC ATC GTC TTC TCC AGC 162
Y E L S V L C D A E V A L I V F S S
AGA GGG AGA CTT TAT GAA TTT GCC AAC CAC AGC GTG AAG AGG ACG ATT GAG AGG 216
R G R L Y E F A N H S V K R T I E R
TAC AAG AAG ACT TGC GTT GAC AAC AAC CAC GGA GGG GCG ATA TCA GAG TCC AAT 270
Y K K T C V D N N H G G A I S E S N
TCT CAG TAT TGG CAA CAG GAG GCT GGT AAA CTC AGA CAA CAG ATT GAC ATT TTG 324
S Q Y W Q Q E A G K L R Q Q I D I L
CAA AAT GCA AAT AGG CAT TTG ATG GGT GAC GGG CTT ACA GCT TTG AAC ATT AAG 378
Q N A N R H L M G D G L T A L N I K
GAA CTC AAG CAA CTT GAG GTT CGA CTT GAA AAA GGA ATC AGC CGA GTG CGA TCC 432
£ J j K Q L E V R L E K G I S R V R S
AAA AAG AAC GAG ATG TTG CTT GAA GAG ATC GAC ATC ATG CAG AGA AGG GAA CAC 486
K K N E M L L E E I D I M Q R R E H
ATA e r r ATC CAG GAG AAT GAG ATT CTT CGC AGC AAG ATA GCC GAG TGT CAG AAT 540
I L I Q E N E I L R S X X A E C 0 N
AGC CAC AAC ACG AAC ATG TTA TCA GCT CCG GAA TAT GAT GCA CTG CCC GCA TTC 594
S H N T N M L S A P E Y D A L P A F
GAC TCT CGA AAT TTC CTA CAT GCA AAT CTA ATC GAT GCG GCC CAT CAC TAT GCA 648
D S R N F L H A N E X D A A H H Y A
CAT CAG GAA CAA ACA ACG CTT CAG CTT GGC TGA ACG TTG AAG CGG TGG ACG CTT 702
H Q £ Q T T L Q L G *
AAA ACT CAA TCA AGG CAC CCG AAA AAT ATG CTA GTA ACC TTG AAT GAG ATT CAG 756
AGT CGA AAT ATT GCG AGG CAA GAG CAC AAT GGA AGA GAT AGC TCC TAG TAT GAA 810
TAT GGA I T T ATG ATA TTA ACA TAT GGT TTG TCA GCT TTA AAT ATA GCT GTT TGA 864
AAC AAA GAA TAC AAC ATA TTA GCT AGT ATT TTT TTG GCG CAT GTT ATC TT T CTG 918
TTG 921
FIGURE 1
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FIGURE 2
AAACTCGACAGCAAATATGATTTAGATTATGACCTAGAAATAAGCATAGCATTAAAGCAT 6 0 
ATACATAACAAGCGGTGATATACTCTGACTGCCACTGTACTTGAGGAAAGGTAGTGGACT 1 2 0  
CTGCTCAGGTACATTAGTTTGGTAAGGTTGGCTTGGCTTCTGGGTAATATGAGAAGTAAA 1 8 0  
GAAGTAAAAGGTATTTGACTCTAGTCAAGTACATTGGATTGCCTTTGTCGGGGCTTGGAT 2 4 0  
GGCTTGGGTTCGTGTGAGAAGCCAACAATTTATAAGAAATATATAAAATAAAAAATAAAA 3 0 0  
AAATTTAAGTGTTGGAAGTGAAAACGGTGGGGCAGAAATATACACAGAAGAGTACTTTAA 3 6 0  
CAATGCGCAACCAAGGCAGATTCACAACTTGATTTCTGGACCTCGAATACGAGATAATGG 4 2 0  
TGGTAAGAAATAAAGGAAGAGTGGAGTGCATTTGAAAATGAATGGAGAGCGCACAAAATG 4 8  0 
GAGGACGAATAAATGAAATATAATGCAAGAGTGCATTTCCCTATTATTTCCAGAAATGTA 5 4 0  
TATGTGGGGTCGGCATTCACATGGGCGTCGCATTCAGGGGGTGTCATAGCGGTCCTTTGA 6 0 0  
TTGCAGTGTGGGAGTTGCAACATGTACCAACAAATCCATTCATCCCAAAACCTAAATTTA 6 6 0  
TCCTCTCCATTACTATTACCTACACCTATACCTAGTAAATATGTCCTGCCTTGTAACTCC 7 2 0  
TCCACTGCCTGCACACGTCTTAGTCAATCCATCTGCCTTCAAATAGGCATTATTTTGTTC 7 8 0  
TTTCCCCTCCGACTGAAAGGCTATCGACCGACCGACCGCTCATCTTCTTCTTCTGCGCAA 8 4 0  
TTTTTTCTGCTGGATCATCATCATTACCATCATCGCCATCCCCACCATCATCATCATGAT 9 0 0  
GGTATCTCTATCTCTCCCTGGCAATCGATTGTAGAGGAAAGGAAGAGGGAAGGGGCATAT 9 6 0  
GTATTGATCAACCTACCCGAAAAAACAATCTGATCAGCCCTGCTCAATCTTGCTTATAAA 1 0 2 0  
TCTCTTATCCACTGTTCAATCATTCAGGTTTCTTCCCACTTTCAAGCAAAGGCGCCCGGA 1 0 8 0  
TTGGCCGTGTTCTTAGATTTTCAGGTACTTAAATGGACAATATTCCCCACCTGAAGCCGT 1 1 4 0  
TCTGAAAAAGATTTGTTTGTAGAAACAAACGATTGTAATATTTGCTTAAGTTG AGCTTAA 1 2 0 0  
GGGGTTTGGTACCTAACTTGCCTTGTGGTTATTTGTTTCTCAGAACTCGGGCTGCGTCCA 1 2 6 0  
ACTGTAGGAACGAACCAGCACAAGGGGTTGCAGCTTTTGCTGTTGCTGTTGCGCCCATTG 1 3 2 0  
CTTTTGGACTGGTATTAGTAGTTGCAGCTTTGTTTTGCATACGCTGTGAGGATCTGTGCG 13 80  
CGGAAATTTTGTGTACAAATC 1 4 0 1
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Cl C2 C3 la  lb 2 3a 3b 3c 4a 4b
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PLANTS HAVING MODIFIED 
REPRODUCTIVE CAPACITY
This application was filed under 35 U.S.C. 371, based on 
PCT/NZ00/00031, which application was filed Mar. 17, 
2000 and claims priority from New Zealand Application No. 
334715, filed March 17; 1999.
This invention relates to plants having modified repro­
ductive capacity. In particular, it relates to a plant reproduc­
tive tissue specific promoter and its use in promoting 
transcription/expression of associated genes in plant repro­
ductive tissue, including for the purpose of producing plants 
which have diminished reproductive capacity or which are 
sterile.
INTRODUCTION
It is desirable that the genetic basis of reproduction/flower 
development in plants be determined. Identification of genes 
involved in plant reproduction and/or flower development 
together with the regulatory elements which control their 
expression in reproductive tissue allows for modulation of 
the reproductive capacity of plants and specifically enables 
the production of reproductively null (sterile) plants.
Identification of the regulatory elements involved further 
allows for the expression in reproductive tissue of genes 
which are heterologous to the plant where that is desirable.
The applicants have now identified and isolated such a 
reproductive tissue specific promoter which endogenously 
regulates expression of a peptide involved in the reproduc­
tive cycle of Firms radiata. It is broadly towards this 
promoter, to its homologs in other plants and to its use in 
effecting expression of associated genes within the repro­
ductive tissue of plants that the present invention is directed.
SUMMARY OP THE INVENTION
In a first aspect, the present invention provides a poly­
nucleotide which has a nucleotide sequence of from nucle­
otides 1 to 1320 of FIG. 2 and which has the ability, when 
operatively associated with a nucleotide sequence encoding 
a peptide, to promote transcription of that nucleotide 
sequence, or a polynucleotide which is a functionally 
equivalent variant thereof.
In a second aspect, the invention provides a plant repro­
ductive tissue promoter which has a nucleotide sequence of 
from nucleotides 1 to 1320 of FIG. 2, or a functionally 
equivalent variant thereof.
In a further aspect, the invention provides a DNA con­
struct which comprises:
(a) a polynucleotide having activity as a transcriptional 
promoter as described above;
(b) an open reading frame polynucleotide coding for a 
peptide; and
(c) a termination sequence.
In yet a further aspect, the invention provides a DNA 
construct which comprises:
(a) a promoter sequence as defined above;
(b) an open reading frame polynucleotide coding for a 
peptide; and
(c) a termination sequence.
In each construct the open reading frame can be in a sense 
orientation, or an anti-sense orientation.
In one embodiment, the open reading frame polynucle­
otide encodes a peptide having the sequence of FIG. 1.
In other embodiments, the open reading frame polynucle­
otide encodes a peptide which, when expressed in repro­
1
ductive tissue of a plant, causes said plant’s reproductive 
organs to abort, to redefine themselves as vegetative, or to 
stop development.
In still another embodiment, the open reading frame 
polynucleotide encodes a peptide which, when expressed in 
the reproductive tissue of a plant, causes cell death.
In yet another embodiment, the open reading frame poly­
nucleotide encodes a peptide, which when expressed in 
reproductive tissue of a flowering plant, causes an alteration 
in the timing of flowering of said plant.
In a preferred form, the construct further includes:
(d) a selection marker sequence.
In a further aspect, the invention provides a transgenic 
plant cell which includes a construct as described above.
By “transgenic” as used herein, the applicants mean 
containing non-endogenous genetic material.
In another aspect, the invention provides a transgenic 
plant which includes a construct as described above.
In still another aspect, the invention provides a transgenic 
plant which contains a polynucleotide having activity as a 
transcriptional promoter as described above or a reproduc­
tive tissue promoter as described above, which plant has a 
reduced reproductive capacity.
It is particularly preferred that the plant be sterile.
Conveniently, in said plant said polynucleotide or pro­
moter is operatively associated with a nucleotide sequence 
encoding a RNAse.
The plant can be a coniferous plant, such as a coniferous 
plant of the Firms genus, or a tree such as a member of the 
Eucalyptus genus.
It is particularly preferred that the transgenic plant be a 
member of a species selected from Firms radiata, Firms 
taeda, Firms elliotti, Firms cause, Firms palustrus, Firms 
echinata, Firms ponderosa, Firms Jeffrey, Firms resinosa, 
Pinus rigida, Firms banksiana, Pinus serotina, Firms 
strobus, Pinus monticola, Pinus lambertiana, Pinus 
virginiana, Pinus contorta, Pinus cariboea, Pinus pinaster, 
Pinus brutia, Pinus eldarica, Pinus coulteri, Pinus nigra, 
Pinus sylvestris, Pinus tecunumannii, Pinus keysia, Pinus 
oocarpa and Pinus maxinumoii.
DESCRIPTION OF THE DRAWINGS
While the invention is broadly as defined above, it will be 
appreciated by those persons skilled in the art that it is not 
limited thereto and that it further includes embodiments of 
which the following description provides examples. In 
addition, the invention will be better understood through 
reference to the accompanying drawings in which:
FIG. 1 shows the amino acid sequence (SEQ ID NO:4) of 
the reproductive peptide PrAGl, together with the nucle­
otide sequence coding therefor (SEQ ID NO:3):
FIG. 2 shows the sequence of the PrAGl promoter, which 
is the focus of the present invention, isolated from Pinus 
radiata (SEQ ID NO:2):
FIG. 3 is an RNA gel blot analysis of PrAGl mRNA 
accumulation in Pinus radiata organs. Twenty fig of total 
RNA from various organs was electrophoresed, blotted onto 
nylon membranes, and hybridized with 3'-terminal fragment 
of PrAGl cDNA. Total RNA was isolated from immature 
male cone (M), immature female cone (F), vegetative shoot 
(V)s, needle (N) and stem (S). The 26S and 18S rRNA was 
used as control (bottom);
FIG. 4 is a DNA gel blot analysis of Pinus radiata 
genomic DNA hybridized with the 3' terminal region of 
PrAGl. 20 fig genomic DNA was digested with BamHI 
(BA) and Bgl II (BG) EcoRI (E), Hindlll (H), Xhol (X);
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FIG. 5 is a Reverse Transcription-Polymerase Chain 
Reaction (RT-PCR) analysis showing reproductive-organ 
specific expression of PrAGl. RT-PCR analysis was per­
formed on total RNA isolated from different organs of 
radiata Pine: (M) immature male cone, (F) immature female 
cone, (Vs) vegetative shoot, (N) needle and (S) stem. MADS 
box genes were amplified with PrAGl gene-specific oligo­
nucleotides. Products from the PCR reactions were 
electrophoresed, blotted, and hybridized with a labelled 
probe of PrAGl specific fragment; from the PCR reactions 
were electrophoresed, blotted, and hybridized with a 
labelled probe of PrAGl specific fragment;
FIG. 6 shows the construction of pRAGPR;
FIG. 7. PCR analysis of transgenic tobacco lines. 
Genomic DNA (200 ng each) from controls and putative 
transgenic tobacco plants was used as template along with 
primers for NPTII gene. Lane PC is positive control (20 ng 
pRAGPR plasmid was used as a template); C1-C3 are 
control nontransformed tobacco plants; lanes la , lb , 2, 3a, 
3b, 3c, 4a, 4b are transgenic plants. The size of NPTII gene 
PCR product is indicated on the right;
FIG. 8 . Southern analysis of transgenic and control 
tobacco lines to confirm integration of PrAGl promoter- 
RNAse gene cassette. Genomic DNA (20 ug each) was 
digested with Hind III and Sac I enzymes, electrophoresed 
and transferred to a nylon membrane. 32-p labeled RNAse 
gene was used as a probe. The size of PrAGl promoter- 
RNAse gene cassette is indicated on the right. Designation 
of control and transgenic plants is as indicated in FIG. 7; and
FIG. 9. Southern analysis of transgenic and control 
tobacco lines to confirm integration profiles of PrAGl 
promoter-RNAse gene cassette. Genomic DNA(20 ug each) 
was digested with Hind III enzyme, electrophoresed and 
transferred to a nylon membrane. 32-P labeled RNAse gene 
was used as a probe. Sizes of DNA fragments hybridizing to 
the RNAse gene probe are indicated on the right. Designa­
tion of control and transgenic plants is as indicated in FIG. 
7.
DESCRIPTION OF THE INVENTION
As broadly outlined above, the applicants have identified 
a plant promoter which is involved in plant reproduction. 
The promoter, which was isolated from Pinus radiata is 
called herein the “PrAGl promoter”.
The nucleotide sequence of the PrAGl promoter is given 
in FIG. 2 from nucleotides 1 to 1320. It will however be 
appreciated that the invention is not restricted only to the 
polynucleotide having that specific nucleotide sequence. 
Instead, the invention also extends to functionally equivalent 
variants of that polynucleotide.
The phrase “functionally equivalent variants” recognises 
that it is possible to vary nucleotide sequence while retaining 
substantially equivalent functionality. Variants can have a 
greater or lesser degree of homology as between the variant 
nucleotide sequence and the original.
Polynucleotide sequences may be aligned, and percentage 
of identical nucleotides in a specified region may be deter­
mined against another sequence, using computer algorithms 
that are publicly available. Two exemplary algorithms for 
aligning and identifying the similarity of polynucleotide 
sequences are the BLASTN and FASTA algorithms. The 
BLASTN software are available on the NCBI anonymous 
FTP server (ftp ://ncb i.n lm .n ih .gov) under /b last/ 
executables/. The BLASTN algorithm version 2.0.4 [Feb. 
24, 1998], set to the default parameters described in the 
documentation of variants according to the present inven­
3
tion. The use of the BLAST family of algorithms, including 
BLASTN, is described at NCBI’s website at URL http:// 
www.ncbi.nlm.nih.gov/BLAST/newblast.html. The com­
puter algorithm FASTA is available on the Internet at the ftp 
site ftp://ftp.virginia.edu/pub/fasta/. Version 2.0 u4, Febru­
ary 1996, set to the default parameters described in the 
documentation and distributed with the algorithm, is also 
preferred for use in the determination of variants according 
to the present invention. The use of the FASTA algorithm is 
described in W. R. Pearson and D. J. Lipman, “Improved 
Tools for Biological Sequence Analysis”, Proc. Natl. Acad. 
Sci. USA 85:2444-2448 (1988).
The following running parameters are preferred for deter­
mination of alignments and similarities using BLASTN that 
contribute to E values (as discussed below) and percentage 
identity Unix running command: blastall -p blastn -d embldb 
-e 10-G 1-E 1-r 2-v 50-b 50-1 queryseq -o results; and 
parameter default values:
-p Program Name [String]
-d Database [String]
-e Expectation value (E) [Real]
-G Cost to open a gap (zero invokes default behaviour)
[Integer]
-E Cost to extend a cap (zero invokes default behaviour)
[Integer]
-r Reward for a nucleotide match (blastn only) [Integer]
-v Number of one-line descriptions (V) [Integer]
-b Number of alignments to show (B) [Integer]
-i Query File [File In]
-o BLAST report Output File [File Out] Optional
The “hits” to one or more database sequences by a queried 
sequence produced by BLASTN, FASTA, or a similar 
algorithm, align and identify similar portions of sequences. 
The hits are arranged in order of the degree of similarity and 
the length of sequence overlap. Hits to a database sequence 
generally represent an overlap over only a fraction of the 
sequence length of the queried sequence.
The BLASTN and FASTA algorithms also produce 
“Expect” or E values for alignments. The E value indicates 
the number of hits one can “expect” to see over a certain 
number of contiguous sequences by chance when searching 
a database of a certain size. The Expect value is used as a 
significance threshold for determining whether the hit to a 
database, such as the preferred EMBL database, indicates 
true similarity. For example, an E value of 0.1 assigned to a 
hit is interpreted as meaning that in a database of the size of 
the EMBL database, one might expect to see 0.1 matches 
over the aligned portion of the sequence with a similar score 
simply by chance. By this criterion, the aligned and matched 
portions of the sequences then have a 90% probability of 
being the same. For sequences having an E value of 0.01 or 
less over aligned and matched portions, the probability of 
finding a match by chance in the EMBL database is 1% or 
less using the BLASTN or FASTA algorithm.
It is also recognised that as the function of the polynucle­
otide is as a transcriptional promoter there are regions of the 
polynucleotide which are more critical to, and characteristic 
of, this function than others. An example are the TATA boxes 
at positions 280 to 286, 282 to 288 and 1015 to 1021 from 
the 5' end of the sequence. Therefore, polynucleotides which 
include these regions of the polynucleotide of FIG. 2 and 
have equivalent transcriptional functionality are contem­
plated variants, even where there is a lesser degree of 
homology elsewhere in the sequence.
According to one embodiment, “variant” polynucleotides, 
with reference to the polynucleotide of the present 
invention, preferably comprise sequences having the same
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number or fewer nucleic acids than the polynucleotide of the 
present invention and producing an E value of 0.01 or less 
when compared to the polynucleotide of the present inven­
tion. That is, a variant polynucleotide is any sequence that 
has at least a 99% probability of being the same as the 
polynucleotide of the present invention, measured as having 
an E value of 0.01 or less using the BLASTN or FASTA 
algorithms set at the parameters discussed above.
Variant polynucleotide sequences will also generally 
hybridize to the recited polynucleotide sequence under strin­
gent conditions. As used herein, “stringent conditions” refers 
to prewashing in a solution of 6xSSC, 0.2% SDS; hybrid­
izing at 65° C., 6xSSC, 0.2% SDS overnight; followed by 
two washes of 30 minutes each in lxSSC, 0.1% SDS at 65° 
C. and two washes of 30 minutes each in 0.2xSSC, 0.1% 
SDS at 65° C.
It is of course expressly contemplated that homologs to 
the PrAGl promoter exist in other plants, particularly other 
coniferous plants, including other members of the Pinus 
genus. Such homologs are also “functionally equivalent 
variants” of PrAGl promoter as the phrase is used herein.
DNA sequences from plants other than Pinus radiata 
which are homologs of the PrAGl promoter may be isolated 
by high throughput sequencing of cDNA libraries prepared 
from such plants. Alternatively, oligonucleotide probes 
based on the sequence for the PrAGl promoter provided in 
FIG. 2 can be synthesized and used to identify positive 
clones in either cDNA or genomic DNA libraries from other 
plants by means of hybridization or PCR techniques. Probes 
should be at least about 10, preferably at least about 15 and 
most preferably at least about 20 nucleotides in length. 
Elybridization and PCR techniques suitable for use with such 
ligonucleotide probes are well known in the art. Positive 
clones may be analyzed by restriction enzyme digestion, 
DNA sequencing or the like.
The polynucleotides of the present invention may be 
generated by synthetic means using techniques well known 
in the art. Equipment for automated synthesis of oligonucle­
otides is commercially available from suppliers such as 
Perkin Elmer/Applied Biosystems Division (Foster City, 
Calif.) and may be operated according to the manufacturer’s 
instructions.
The PrA G l prom oter of the invention is plant 
reproductive-tissue-specific. The primary importance of 
identification of the polynucleotide of the invention is there­
fore that it enables the reproductive capacity of plants to be 
modulated. This modulation will generally involve a reduc­
tion in the reproductive capacity of the plant.
Any conventional technique for effecting this can be 
employed. Examples include co-suppression or anti-sense 
strategies, a dominant negative approach, or techniques 
which involve expressing enzymes (such as RNAses) to 
digest, or otherwise be lethal to, RNA post-transcription of 
a target gene.
Co-suppression can be effected in a manner similar to that 
discussed, for example, by Napoli et al (Plant Cell 
2:279-290, 1990) and de Carvalho Niebel et al (Plant Cell 
7:347-258, 1995). In some cases, it can involve overexpres­
sion of the gene of interest through use of multiple con­
structs of the PrAGl promoter and gene to be suppressed.
Anti-sense strategies involve using the PrAGl promoter 
to effect expression or transcription of DNA with the 
expression/transcription product being capable of interfering 
with translation of mRNA transcribed from the gene to be 
suppressed. This will normally be through the expression/ 
transcription product hybridising to and forming a duplex 
with the target mRNA.
5
The expression/transcription product can be a relatively 
small molecule and still be capable of disrupting mRNA 
translation. However, the same result is achieved by express­
ing the target gene in an anti-sense orientation such that the 
RNA produced by transcription of the anti-sense oriented 
gene is complementary to all or part of the endogenous 
target mRNA.
Such anti-sense strategies are described generally by 
Robinson-Benion et al., (1995), Anti-sense techniques, 
Methods in Enzymol. 254(23):363-375 and Kawasaki et al., 
(1996), Artific. Organs 20 (8): 836-848.
Dominant negative approaches involve using the PrAGl 
promoter to effect the expression of a modified DNA 
binding/activating protein which includes a DNA binding 
domain but not a activator domain. The result is that the 
protein binds to DNA as intended but fails to activate, while 
at the same time blocking the binding of the DNA binding/ 
activating peptides which normally bind to the same site.
It is however presently preferred that the reproductive 
capacity of the plant be reduced or eliminated through the 
use of the PrAGl promoter to drive transcription and 
expression of a nucleotide sequence which encodes an 
RNAse within the plant reproductive tissue. Such an 
approach, in which the PrAGl promoter is coupled to the 
RNAse, RNS2, is exemplified herein.
To give effect to the above strategies, the invention also 
provides DNA constructs. The constructs include the PrAGl 
promoter sequence, the DNA intended to be transcribed/ 
expressed (such as the PrAGl gene in sense or in anti-sense 
orientation or a polynucleotide encoding an RNAse) and a 
termination sequence, operably linked to the DNA sequence 
to be transcribed. The promoter sequence is generally posi­
tioned at the 5' end of the DNA sequence to be transcribed, 
and is employed to initiate transcription of the DNA 
sequence.
The DNA with which the PrAGl promoter is operatively 
associated can encode any peptide it is desirable to express 
in plant reproductive tissue. As indicated above, this 
includes the peptide encoded by PrAGl, but can also be 
another peptide. That other peptide can be a peptide which, 
when produced, causes the reproductive organs of the plant 
to abort, redefine themselves as vegetative or stop develop­
ment. The peptide encoded can, for example, also be a 
peptide causing cell death. Illustrative peptides/genes are 
Diphtheria Toxin A (DTA), Barnase (from Bacillus 
amyloliquefaciens), apoptosis genes, glucanase, and 
RNAses, with the selection of each being a matter of choice 
for the art skilled worker.
Alternatively, the peptide which is to be expressed under 
the control of the PrAGl promoter can be one which, when 
produced, alters the timing of flowering (ie. either delays or 
accelerates flowering, such as the ELF-3 and CONSTANS 
flowering time genes).
The peptide to be expressed can be ligated to the promoter 
in a sense or antisense orientation, dependant upon the 
desired effect.
The termination sequence, which is located 3' to the DNA 
sequence to be transcribed, may come from the same gene 
as the PrAGl promoter or may be from a different gene. 
Many termination sequences known in the art may be 
usefully employed in the present invention, such as the 3' 
end of the Agrobacterium tumefaciens nopaline synthase 
gene. However, preferred termination sequences are those 
from the original gene or from the target species to be 
transformed.
The DNA constructs of the present invention may also 
contain a selection marker that is effective in plant cells, to
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allow for the detection of transformed cells containing the 
construct. Such markers, which are well known in the art, 
typically confer resistance to one or more toxins. One 
example of such a marker is the NPTII gene whose expres­
sion results in resistance to kanamycin or hygromycin, 
antibiotics which are usually toxic to plant cells at a mod­
erate concentration (Rogers et al., in Methods for Plant 
Molecular Biology, A Weissbach and H Weissbach eds, 
Academic Press Inc., San Diego, Calif. (1988)). Other 
examples of markers include visible selection markers such 
as Green Fluorescent Protein (GFP) and herbicide resistance 
genes. Alternatively, the presence of the desired construct in 
transformed cells can be determined without reference to 
marker genes, by means of other techniques well known in 
the art, such as Southern and Western blots.
Techniques for operatively linking the components of the 
DNA constructs are well known in the art and include the 
use of synthetic linkers containing one or more restriction 
endonuclease sites as described, for example, by Maniatis et 
al., (Molecular Cloning: A Laboratory Manual, Cold Spring 
Flarbour Laboratories, Cold Spring Flarbour, N.Y., 1989). 
The DNA construct may be linked to a vector having at least 
one replication system, for example, E. coli, whereby after 
each manipulation, the resulting construct can be cloned and 
sequenced and the correctness of the manipulation deter­
mined.
The DNA constructs of the present invention may be used 
to transform a variety of plants. In one embodiment, these 
will be plants of the Pinus genus. In a preferred embodiment, 
the DNA constructs are employed to transform Pinus 
radiata, Pinus taeda, Pinus elliotti, Pinus clausa, Pinus 
palustrus, Pinus echinata, Pinus ponderosa, Pinus Jeffrey, 
Pinus resinosa, Pinus rigida, Pinus banksiana, Pinus 
serotina, P inus strobus, P inus m onticola, P inus  
lambertiana, Pinus virginiana, Pinus contorta, Pinus 
cariboea, Pinus pinaster, Pinus brutia, Pinus eldarica, 
Pinus coulteri, Pinus nigra, Pinus sylvestris, Pinus 
tecunumannii, Pinus keysia, Pinus oocarpa and Pinus 
maxinumoii, and hybrids between the above species.
The constructs can also be used to transform other plants 
such as trees selected from Abies amabilis, Abies balsamea, 
Abies concolor, Abies grandis, Abies lasiocarpa, Abies 
magnifica, Abies procera, Chamaecyparis lawsoniona, 
Chamaecyparis nootkatensis, Chamaecyparis thyoides, 
Huniperus virginiana, Larix decidua, Larix laricina, Larix 
leptolepis, Larix occidentalis, Larix siberica, Libocedrus 
decurrens, Picea abies, Picea engelmanni, Picea glauca, 
Picea mariana, Picea pungens, Picea rubens, Picea 
sitchensis, Pseudotsuga menziesii, Sequoia gigantea, 
Sequoiasem pervirens, Taxodium distichum , Tsuga 
canadensis, Tsuga heterophylla, Tsuga mertensiana, Thuja 
occidentalis, Thuja plicata; Eucalypts, such as Eucalyptus 
alba, Eucalyptus bancroftii, Eucalyptus botyroides, Euca­
lyptus bridgesiana, Eucalyptus calophylla, Eucalyptus 
cam aldulensis, E ucalyptus citriodora, Eucalyptus  
cladocalyx, Eucalyptus coccifera, Eucalyptus curtisii, Euca­
lyptus dalrympleana, Eucalyptus deglupta, Eucalyptus 
delagatensis, Eucalyptus diversicolor, Eucalyptus dunnii, 
Eucalyptus ficifolia, Eucalyptus globulus, Eucalyptus 
gomphocephala, Eucalyptus gunnii, Eucalyptus henryi, 
Eucalyptus laevopinea, Eucalyptus macarthurii, Eucalyptus 
m acrorhyncha, E uca lyp tus m aculata, E ucalyp tus  
marginata, Eucalyptus megacarpa, Eucalyptus melliodora, 
Eucalyptus nicholii, Eucalyptus nitens, Eucalyptus 
novaanglica, Eucalyptus obliqua, Eucalyptus obtusiflora, 
Eucalyptus oreades, Eucalyptus pauciflora, Eucalyptus 
polybractea, Eucalyptus regnans, Eucalyptus resinifera,
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Eucalyptus robusta, Eucalyptus rudis, Eucalyptus saligna, 
Eucalyptus sideroxylon, Eucalyptus stuartiana, Eucalyptus 
tereticornis, Eucalyptus torelliana, Eucalyptus urnigera, 
Eucalyptus urophylla, Eucalyptus viminalis, Eucalyptus 
viridis, Eucalyptus wandoo and Eucalyptus youmanni; and 
hybrids between any of the above species.
As discussed above, transformation of a plant with a DNA 
construct including an open reading frame coding for a 
peptide wherein the open reading frame is orientated in a 
sense direction can, in some cases, lead to a decrease in 
expression of the peptide by co-suppression. Transformation 
of the plant with a DNA construct comprising an open 
reading frame in an anti-sense orientation or a non-coding 
(untranslated) region of a gene will lead to a decrease in the 
expression of the peptide in the transformed plant.
Techniques for stably incorporating DNA constructs into 
the genome of target plants are well known in the art and 
include Agrobacterium tumefaciens mediated introduction, 
electroporation, protoplast fusion, injection into reproduc­
tive organs, injection into immature embryos, high velocity 
projectile introduction and the like. The choice of technique 
will depend upon the target plant to be transformed.
Once the cells are transformed, cells having the DNA 
construct incorporated into their genome may be selected by 
means of a marker, such as the NPT II or kanamycin 
resistance markers discussed above. Transgenic cells may 
then be cultured in an appropriate medium to regenerate 
whole plants, using techniques well known in the art. In the 
case of protoplasts, the cell wall is allowed to reform under 
appropriate osmotic conditions. In the case of seeds or 
embryos, an appropriate germination or callus initation 
medium is employed. For explants, an appropriate regen­
eration medium is used.
For a review of regeneration of forest trees such as those 
of the Pinus genus, see Dunstan et al., Somatic embryogen- 
esis in woody plants. In: Thorpe, T. A. ed. 1995: in vitro 
embryogenesis of plants. Vol 20 in Current Plant Science 
and Biotechnology in Agriculture, Chapter 12, pp. 471-540.
The promoter, and constructs containing it, are not 
restricted in use to plants of forestry species. They can also 
be used to transform other agronomically important plants in 
which modulation of reproductive capacity (particularly the 
timing and abundance of flowering) is desirable. Such plants 
include cereals, rice, maize, wheat, barley, oats, rye, soya­
bean and canola.
The resulting transformed plants may be reproduced 
sexually or asexually, using methods well known in the art, 
to give successive generations of transgenic plants.
The invention will now be described with reference to the 
following non-limiting examples.
EXPERIMENTAL
Section 1
1. PrAGl cDNA Cloning:
Total RNA was purified from immature cone of radiata 
pine according to the protocol of Charles Ainsworth (Plant 
Molecular Biology Reporter, 12(3), 1994: 198-203). The 
mRNA was isolated with oligo-T cellulose column. With 
mRNA as template, the cDNA was synthesised with Cap- 
Finder cDNA synthesis kit (ClonTech Co.). The cDNA was 
inserted into Lambda TriplEx Vector (ClonTech Co.), then 
packaged it with Gigapack@ III packaging extracts 
(Stratagene Co.) to obtain a cDNA library.
Two degenerate primers were designed:
3' PCR primer: 5' GCIGTIAGIYCITCICCCAT 3'; (SEQ ID
NO: 7)
5' PCR primer: 5' AAYCGICARGTIACITT 3' (SEQ ID
NO: 8)
8
5
10
15
20
25
30
35
40
45
50
55
60
65
US 6,858,776 B1
These primers were used to perform RT-PCR based 
differential screening on RNA from various female tissue 
sources, including immature female buds, vegetative tissue 
from needles and later stages of development. The 50-ul 
reaction mixture contained 2.5 Units Taq DNA polymerase, 
fx  Polymerization Buffer (both from ClonTech Co.), f 
mMMgCl2, 0.2 mMdNTP and 0.25 uM primers. The PCR 
was performed under the following conditions: denaturation 
at 94° C. for 30 s, annealing at 50° C. for f min and 
extension at 72° C. for f min for 30 cycles on a Thermal 
Cycler 480 (Perkin-Elmer, Norwalk, Conn., USA).
Fragments were obtained mostly from immature female 
bud tissue RNA samples. Several DNA fragments were 
cloned into pGEM-T vector and sequenced. Sequence analy­
sis showed that most of these fragments contained similar 
sequences. One of the DNA fragments (309 bp) was chosen. 
This was used as a probe to screen the cDNA library to clone 
its full-length cDNA and resulted in the cDNA clone, 
PrAGl. The sequence of PrAGl was analysed on both 
strands by the Sanger’s dideoxy method (Sanger et al., 1977, 
Proc. Natal. Acad. Sci. U.S.A. 74: using a Sequenase kit 
(United States Biochemical co.).
The resulting sequence is shown in FIG. 1 gives the 
nucleotide sequence coding for the peptide of the invention 
together with the predicted amino acid sequence.
Sequence comparison and phylogenetic analysis were 
conducted with the software program MacDNASIS (Version 
3.5, Hitachi Corp.). The results of analysis revealed PrAGl 
to be a MADS box gene.
2. PrAGl Promoter Cloning:
I. Genomic DNA Purification:
Genomic DNA was purified from young needles accord­
ing to a CTAB method as described below.
1) 2 g of young needles of Pinus radiata were ground in 
liquid nitrogen (mortar and pestle) to a fine powder.
2) This powder was mixed with 15 mL of pre-warmed 
CTAB extraction buffer [3% CTAB (W/V), 100 mM Tris- 
HC1 pH8.0, 20 mM EDTA pH8.0, 1.4 M NaCl, 1% PVP 
940,000, 1% beta mercaptoethanol] and incubated at 65° C. 
for one hour.
3) To the above mixture 15 mL chloroform was added and 
mixed gently.
4) The contents were centrifuged at 10,000 g for 20 
minutes at 4° C.
5) The supernatant was transferred to a new tube, and 
mixed with Vio volume of 3M sodium acetate (pH4.8), and 
0.7 volume of isopropanol. The DNA was precipitated at 
-20° C. for 30 minutes.
6) The DNA was pelleted at 10,000 g for 10 minutes at 4° 
C.
7) The DNA pellet was then air dried and resuspended in 
2 mL TE buffer (10 mM Tris-HCl pH7.5, 1 mM EDTA 
pH8.0) and 2,&1 of RNAse A (10 fig/fiV) was added. The 
contents were incubated at 37° C. for 30 minutes to remove 
any RNA from the sample.
8) After the incubation, 2 mL of 5M Ammonium acetate 
and 10 mL of 100% ethanol were added and the contents 
kept at -20° C. for 15 minutes.
9) The mixture was then centrifuged at 10,000 g for 10 
minutes at 4° C. to pellet DNA. The DNApellet was washed 
in 70% ethanol twice.
10) The DNA pellet was air dried and resuspended in 200 
uL TE bufffer.
II. Cloning of PrAGl Promoter with Two Step Genomic 
DNA Walking.
1) The Universal Genome Walker Kit (CLONTECH) was 
employed. For the first step genomic DNA walking, two
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PrAGl specific primers were designed and synthesized 
according to the PrAGl cDNA sequence. The sequences of 
the primers were:
Primer GSP1: 5°c CGC CTT CTT CAA TAA ACC ATT
TCG GCG CTT 3' (SEQ ID NO:9)
Primer GSP2: 5' GAC CTG TCG GTT COT AGT ATT TTC
AAT CCT 3' (SEQ ID NO: 10)
2) Based upon the promoter sequence we got from step 1), 
two PrAGl promoter sequence specific primer were 
designed and synthesized. The primers were:
Primer GSP3: 5' TTC GTC CTC CAT TTT GTG CGC TCT
CCA TTC 3' (SEQ ID N O :ll)
Primer GSP4: 5' GCA CTC CAC TCT TCC TTT ATT TCT
TAC CAC 3' (SEQ ID NO: 12)
3) According to the User Manual of Universal Genome 
Walker Kit, 13 genome walker libraries were constructed 
after genomic DNA digestion with restriction enzymes: 
EcoR V, Sea I, Dra I, Pvu II, Ssp I, Stu I, Sma I, Hap I, BsaB 
I, Bcll36 II, Pml I, Nru I, Hie II.
4) With 13 genome walker libraries as templates, and 
adaptor primer 1 (API primer from kit) and GSP1 primer, 
first round PCR was performed under the conditions sug­
gested by the kit manufacturer. After agarose electrophoresis 
analysis of the PCR product, second round PCR was per­
formed with the nested primers AP2 (Adaptor primer from 
the kit) and GSP2. The PCR products from the second round 
PCR were purified and cloned into pGEM-T easy vector 
(Promega). Following sequence analysis, and DNA 
sequence comparison with PrAGl cDNA, one DNA frag­
ment of 1105 bp from Sea I genome walker library was 
obtained which was identified as the promoter region of 
PrAGl, based upon the overlapped region between it and 
PrAGl cDNA.
5) The second step genome walking was done with primer 
pair API and GSP3, and primer pair AP2 and GSG4. A DNA 
fragment of 449 bp from the Dra I genome walker library 
was identified as the upstream sequence of the PrAGl 
promoter cloned from the first step genome walking based 
on the sequence comparison of overlapped region between 
them.
6) The 1105 bp and 449 bp fragments were used in PCR 
mediated DNA splicing to synthesize one continuous 1458 
pb promoter fragment of PrAGl. This was done as 
described. One primer was synthesized based on the 5'end 
sequence of 1105 bp promoter fragment: Primer PLi, 5' AGT 
TAC TTA ACA ATG CGC MC CAA GGC 3' (SEQ ID NO. 
13). Primer pair PLi and GSP2 was used in PCR to get the 
promoter fragment of 1105 pb, in which the AP2 primer 
sequence was removed. This 1105 bp fragment and 449 bp 
fragment was then added in one PCR tube as a template with 
the primer pair of AP2 and GAP2 to do the second round 
PCR to get the 1458 bp PCR fragment. The conditions of 
second round PCR were as follows: the first cycle at 95° C. 
for 5 minutes, and 68° C. for 10 min; the second cycle at 94° 
C. for 30 seconds (DNA denaturing), DNA annealing at 60° 
C. for 1 min, and DNA synthesis at 72° C. for 2 minutes; this 
regime was cycled 30 times. This 1458 bp fragment was then 
cloned into pGEM-T easy vector (Promega) and subjected to 
DNA sequencing on both strands to confirm the DNA 
sequence and to make sure that no base changes occurred 
during the PCR process.
The sequence of the promoter, (which is the PrAGl 
promoter), is given in FIG. 2 from nucleotides 1 to 1320.
7) DNA sequence analysis has indicated that compared to 
its orthologs from other plants, the PrAGl showed that there 
were two possible positions for transcription initiation: at 
position 791 or 1326 in the FIG. 2 sequence. It was found
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three typical TATA boxes in the PrAGl promoter at the 
position of 280 to 286, 282 to 288, 1015 to 1021. Based on 
the start codon position and short 5' untranslated region in 
the PrAGl cDNA, the transcription initiation point is iden­
tified as position 1326 in the FIG. 2 sequence.
3. DNA and RNA Gel Blot Hybridizations:
Genomic DNA and RNA gel blots were made using 
standard techniques (Sambrook et al., 1989. Molecular 
Cloning: A Laboratory Cold Spring Harbor, N.Y.: Cold 
Spring Harbor Laboratory Press).
RNA: Total RNA was prepared from needle, vegetative 
shoot, stem, immature female cone and immature male cone 
samples as described above. Briefly, 20 fig of total RNA was 
denatured in formaldehyde loading buffer and fractionated 
by denaturing agarose gel electrophoresis on a formaldehyde 
containing gel. The agarose gel was stained with ethidium 
bromide and a picture taken as control. The RNA was then 
transferred to a nylon membrane by the capillary blotting 
method. The RNA was immobilised on the membrane by 
UV cross-linking and was prehybridized at 65° C. for 2 
hours prior to hybridization in 0.5M Na-phosphate, pH 7.2, 
7.5% SDS, 1 mM EDTA, 100 ug/mL salmon sperm DNA. 
A DNA fragment of PrAGl 3' end region was labelled with 
32P_dCTP (Decaprime B kit, Ambion, Austin, Tex.), and 
hybridised to the RNA blot overnight at 65° C. The blot was 
washed twice in 40 mMNa-P04, 1% SDS and 1 mM EDTA 
for 30 minutes each at 65° C., and exposed to X-ray film 
with intensifying screens at 80° C.
DNA: Genomic DNA was prepared from needle tissue 
with CTAB method. Twenty fig genomic DNA was digested 
by Bam HI, Bgl II, Eco RI, Hin III and Xba I respectively. 
After agarose gel running, alkali blotting of DNA to Hybond 
N membranes was performed as described by the manufac­
turer (Amersham). The probe hybridisation and washing 
was as described for the RNA blotting analysis.
The results are shown in FIGS. 3 and 4.
4. RT-PCR:
Analysis was performed on total RNA isolated from 
needle, stem, vegetative shoot, immature female cone and 
immature male cone samples as described above. RNA was 
reverse-transcribed with MMLV reverse-transcriptase 
(Gibco BRL) according to the manufacturer’s instructions. 
PCR was performed with two primers: 5'PCR primer (5' 
TTGTGTACAAATCATGGG 3') (SEQ ID NO: 14) and 
3'PCR primer (5'GTAAGCCCGTCACCCATC 3') SEQ ID 
NO: 15). Verification of the specificity of the PCR reactions 
was achieved through the use of controls that included 
amplification reaction with single primers, RNAse treatment 
of template, and no template. In those reactions in which no 
PCR product was detected, the quality of the RNA was 
tested by UV scanning and agarose gel electrophoresis. 
ss-cDNA from the RT reaction was used as a template. The 
50-ul reaction mixture contained 2.5 U Taq DNA 
polymerase, lx  Polymerization Buffer (both from ClonTech 
Co.), 1 mM MgCl2, 0.2 mM dNTP and 0.25 fiM primers. 
The PCR was performed under following conditions: dena- 
turation at 94° C. for 30 s, annealing at 55° C. for 1 min and 
extension at 72° C. for 1 min for 30 cycles on Thermal 
Cycler 480 (Perkin-Elmer, Norwalk, Conn., USA). The PCR 
products were subjected to electrophoresis in agarose gel 
and hybridization as described above.
The results are shown in FIG. 5.
Discussion
Northern blot hybridization and RT-PCR analysis showed 
that PrAGl mRNAis accumulated specifically in the imma­
ture female cone and immature male cone; there is no 
expression detected in needle, stem, and vegetative shoot
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(FIGS. 3 and 5). This tissue distribution profile, when 
combined with the fact that PrAGl contains a MADS box, 
verifies that PrAGl is a reproductive gene in Pinus radiata 
and that the PrAGl promoter is reproductive-tissue specific.
Southern blot analysis showed that PrAGl gene exists as 
a single copy in the genome of Pinus radiata (FIG. 4). 
Section 2
Construction of Binary Vector pRAGPR, Plant Transforma­
tion and Regeneration f Transgenic Tobacco Plants
A DNA fragment containing the PrAGl promoter (1.40 
kb, SEQ ID NO:2) operably fused to an RNAse gene (0.95 
kb, RNS2, Taylor et al. Proc Natl Acad Sci, USA 90 (11), 
5118-5122 (1993)) and containing Hind III and Sac I sites 
was gel purified and ligated into the Hind III/Sac I sites of 
binary vector pRD420, containing the NPTII gene for plant 
selection, (provided by Dr. R. S. S. Datla, PBI, Saskatoon, 
Canada) resulting in the construct pRAGPR (FIG. 6). The 
construct was introduced into Agrobacterium tumefaciens 
(strain c58 MP90), and used to transform and regenerate 
Nicotiana tabacum var. Xanthi by the standard leaf disc 
transformation ethod (Horsch et al. (1985), A simple and 
general method for transferring genes into plants. Science 
227,1229-1231). Control lines were also generated through 
leaf disk method without the selection process. After kana- 
mycin selection, the putative transgenic plantlets were 
rooted in the rooting medium containing kanamycin and 
then moved to pots containing the Metromix 350 potting 
mix. Potted plants were maintained under controlled condi­
tions in a growth chamber with 16 h photoperiod. The plants 
were grown through the full life cycle of the tobacco until 
senescence and the flowering of the transgenic tobacco 
assessed relative to controls. Transgenic plants were iden­
tified further by PCR with template of genomic DNA and 
Southern blot analysis to confirm the integration of 
pRAGPR in transgenic tobacco plants.
Polymerase Chain Reaction Amplification
To check the genomic DNA integration of pRAGPR in the 
transgenic tobacco plants, gene-specific primers for the 
NPTII gene were employed. The primers used were NPTII- 
5' primer 5-GAACAAGAT GCATTG CAC GC-3' (SEQ ID 
NO: 16) and NPTII-3' primer 5'-GAAGAACTC GTC AAG 
AAG GC-3' (SEQ ID NO: 17). Genomic DNA from each of 
the control lines and transgenic tobacco lines were isolated 
from the leaf tissue using the Qiagen DNAeasy kit as per 
manufacturer’s instructions. PCR reactions (50-/d final 
volume) were performed using 5 fil of template DNA. 
Samples were heated to 95° C. for 4 minutes, followed by 35 
cycles of 95° C. for 45 seconds, 55° C. for 30 seconds, and 
73° C. for 2 minutes, with a final extension step of 73° C. for 
5 minutes in PTC100 thermal cycler (MJ Research). Ampli­
fied DNA fragments were analyzed on a 0.8% agarose gel 
and visualized by staining with ethidium bromide.
DNA Gel Blot Hybridization
To confirm the genomic integration of PrAGl promoter- 
RNAse gene cassette in transgenic plants and to determine 
the copy number, Southern analysis was performed. For 
Southern analysis, genomic DNA (20 fig) was digested with 
appropriate restriction endonucleases, separated by electro­
phoresis in a 0.8% agarose gel. Two sets of Southerns were 
performed, one with digesting the genomic DNA with Hind 
III and Sac I to drop the PrAGl-RNAse cassette and another 
with Hind III digest alone to test for integration profiles. 
Following depurination in 0.25 M HC1 and denaturation in 
0.5 M NaOH, 1.5 M NaCl, the DNA was blotted onto a 
nylon membrane. The RNAse gene-specific probe (which is 
the whole RNAse gene) was radioactively labelled using a 
random-primed DECAprime II DNA labeling kit (Ambion,
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Austin, Tex.). Filters were hybridized at 65° C. in a hybrid­
ization buffer containing 0.5 M NaP04 (pFI 7.5), 7.5% SDS, 
and 1 mM EDTA. All filters were washed finally at 68° C. 
in 20 mM NaP04 (pFI 7.5), 1% SDS. Filters were then 
subjected to autoradiography. 5
Results and Conclusions
Transgenic Tobacco Plants Expressing PrAGl Promoter 
Controlled RNAs Gene.
Eight independent transgenic lines of tobacco (N. tobac- 
cum var Xanthi) with the PrAGl-RNAse fusion construct to 
were obtained together with three control lines processed 
through the same tissue culture propagation method but 
without the selection. PCR was done on the putative trans­
genic plantlets, after rooting in selection medium, to confirm 
the integration of the NPTII gene. All the eight lines were 15 
positive for the NPTII gene and the controls were negative 
(FIG. 7). The transgenic plants were propagated in pots 
along with the controls.
Southern analysis was done on the eight transgenic lines 
and the three controls to confirm the integration and profiles 20 
of integration of PrAGl promoter-RNAse gene cassette. 
Double digestion with Hind III and Sac I followed by 
probing with RNAse gene probe indicated that all the eight 
transgenic plants had the PrAGl-RNAse cassette (FIG. 8). 
The single digest with Hind III indicated that 5 of the 25 
transgenic lines had single integration and three others had 
two copies of the cassette.
Out of the 5 transgenic plants with single integration two 
profiles were found based on molecular weight size bands 
that hybridized to the RNAse probe. Three plants had the 30 
same size band hybridizing at -4  kb (#s 3a, 3 c, 4a) whereas, 
the two other plants had a band hybridizing at -3  kb range 
(#s 3b, 4b)(FIG. 9).
Of the three transgenic plants that had two copies of the 
cassette, two had same profile with a band at 5-6 kb and 35 
another at 4 kb hybridizing to the RNAse probe (#la, lb), 
whereas the other had two bands, one at 8 kb and another at 
4 kb that hybridized to RNAse probe (#2) (FIG. 9).
All the three controls were negative for hybridization with 
the RNAse probe (FIG. 8 and FIG. 9).
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Reproductive Sterility in Transgenic Tobacco Caused by 
pRAGPR.
All the controls and transgenic lines were allowed to 
senesce (approximately 3 months). The controls flowered 
normally whereas none of the transgenic tobacco containing 
the pRAGPR construct flowered. The plants with single 
copy PrAGl-RNAse cassette grew at the same rate as 
controls and senesced at the same time. The transgenic 
plants with two copies of pRAGPR were slower to grow, and 
matured late (#la, lb  and 2).
All transgenic plants eventually died and none flowered.
Another phenotypic change observed was in transgenic 
line #2, which developed additional lateral branches near the 
top. This may be due to the lack of or decreased apical 
dominance in these plants. Thus, the inhibition of flowering 
using the PrAGl-RNAse cassette may have an added benefit 
to increase the biomass of the plant through increased 
branching if the growing conditions are not limiting.
Industrial Application
In its primary aspect, the invention provides a new, 
reproductive-tissue-specific promoter. This promoter can be 
used in transforming a wide variety of plants. The promoter 
can also be used to drive expression of any gene which it is 
desirable to express in plant reproductive organs, including 
flowering time genes.
The invention also has application in modulating, and in 
particular reducing or eliminating reproductive capacity in 
plants including those of the Pinus genus and Eucalyptus 
genus. Such plants have utility in forestry.
The availability of reproductively null or sterile pine or 
eucalyptus trees has the additional advantage that it will be 
possible to introduce further exogenous genetic material into 
those trees without the risk that the material will be passed 
on to other trees.
Those persons skilled in the art will appreciate that the 
specific description provided is exemplary only, and that 
modifications and variations may be made without departing 
from the scope of the invention.
14
SEQUENCE LISTING
<160> NUMBER OF SEQ ID NOS: 17
<210> SEQ ID NO 1
<211> LENGTH: 1320
<212> TYPE: DNA
<213> ORGANISM: Pinus radiata
<400> SEQUENCE: 1
aaactcgaca gcaaatatga tttagattat gacctagaaa taagcatagc attaaagcat 60
atacataaca agcggtgata tactctgact gccactgtac ttgaggaaag gtagtggact 120
ctgctcaggt acattagttt ggtaaggttg gcttggcttc tgggtaatat gagaagtaaa 180
gaagtaaaag gtatttgact ctagtcaagt acattggatt gcctttgtcg gggcttggat 240
ggcttgggtt cgtgtgagaa gccaacaatt tataagaaat atataaaata aaaaataaaa 300
aaatttaagt gttggaagtg aaaacggtgg ggcagaaata tacacagaag agtactttaa 360
caatgcgcaa ccaaggcaga ttcacaactt gatttctgga cctcgaatac gagataatgg 420
tggtaagaaa taaaggaaga gtggagtgca tttgaaaatg aatggagagc gcacaaaatg 480
15
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gaggacgaat aaatgaaata taatgcaaga gtgcatttcc ctattatttc cagaaatgta 540
tatgtggggt cggcattcac atgggcgtcg cattcagggg gtgtcatagc ggtcctttga 600
ttgcagtgtg ggagttgcaa catgtaccaa caaatccatt catcccaaaa cctaaattta 660
tcctctccat tactattacc tacacctata cctagtaaat atgtcctgcc ttgtaactcc 720
tccactgcct gcacacgtct tagtcaatcc atctgccttc aaataggcat tattttgttc 780
tttcccctcc gactgaaagg ctatcgaccg accgaccgct catcttcttc ttctgcgcaa 840
ttttttctgc tggatcatca tcattaccat catcgccatc cccaccatca tcatcatgat 900
ggtatctcta tctctccctg gcaatcgatt gtagaggaaa ggaagaggga aggggcatat 960
gtattgatca acctacccga aaaaacaatc tgatcagccc tgctcaatct tgcttataaa 1020
tctcttatcc actgttcaat cattcaggtt tcttcccact ttcaagcaaa ggcgcccgga 1080
ttggccgtgt tcttagattt tcaggtactt aaatggacaa tattccccac ctgaagccgt 1140
tctgaaaaag atttgtttgt agaaacaaac gattgtaata tttgcttaag ttgagcttaa 1200
ggggtttggt acctaacttg ccttgtggtt atttgtttct cagaactcgg gctgcgtcca 1260
actgtaggaa cgaaccagca caaggggttg cagcttttgc tgttgctgtt gcgcccattg 1320
<210> SEQ ID NO 2 
<211> LENGTH: 1401 
<212> TYPE: DNA 
<213> ORGANISM: Pinus radiata
<400> SEQUENCE: 2
aaactcgaca gcaaatatga tttagattat gacctagaaa taagcatagc attaaagcat 60
atacataaca agcggtgata tactctgact gccactgtac ttgaggaaag gtagtggact 120
ctgctcaggt acattagttt ggtaaggttg gcttggcttc tgggtaatat gagaagtaaa 180
gaagtaaaag gtatttgact ctagtcaagt acattggatt gcctttgtcg gggcttggat 240
ggcttgggtt cgtgtgagaa gccaacaatt tataagaaat atataaaata aaaaataaaa 300
aaatttaagt gttggaagtg aaaacggtgg ggcagaaata tacacagaag agtactttaa 360
caatgcgcaa ccaaggcaga ttcacaactt gatttctgga cctcgaatac gagataatgg 420
tggtaagaaa taaaggaaga gtggagtgca tttgaaaatg aatggagagc gcacaaaatg 480
gaggacgaat aaatgaaata taatgcaaga gtgcatttcc ctattatttc cagaaatgta 540
tatgtggggt cggcattcac atgggcgtcg cattcagggg gtgtcatagc ggtcctttga 600
ttgcagtgtg ggagttgcaa catgtaccaa caaatccatt catcccaaaa cctaaattta 660
tcctctccat tactattacc tacacctata cctagtaaat atgtcctgcc ttgtaactcc 720
tccactgcct gcacacgtct tagtcaatcc atctgccttc aaataggcat tattttgttc 780
tttcccctcc gactgaaagg ctatcgaccg accgaccgct catcttcttc ttctgcgcaa 840
ttttttctgc tggatcatca tcattaccat catcgccatc cccaccatca tcatcatgat 900
ggtatctcta tctctccctg gcaatcgatt gtagaggaaa ggaagaggga aggggcatat 960
gtattgatca acctacccga aaaaacaatc tgatcagccc tgctcaatct tgcttataaa 1020
tctcttatcc actgttcaat cattcaggtt tcttcccact ttcaagcaaa ggcgcccgga 1080
ttggccgtgt tcttagattt tcaggtactt aaatggacaa tattccccac ctgaagccgt 1140
tctgaaaaag atttgtttgt agaaacaaac gattgtaata tttgcttaag ttgagcttaa 1200
ggggtttggt acctaacttg ccttgtggtt atttgtttct cagaactcgg gctgcgtcca 1260
actgtaggaa cgaaccagca caaggggttg cagcttttgc tgttgctgtt gcgcccattg 1320
17
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cttttggact ggtattagta gttgcagctt tgttttgcat acgctgtgag gatctgtgcg 1380 
cggaaatttt gtgtacaaat c 1401
<210> SEQ ID NO 3
<211> LENGTH: 909
<212> TYPE: DNA
<213> ORGANISM: Pinus radiata
<220> FEATURE:
<221> NAME/KEY: CDS 
<222> LOCATION: (1)..(669)
<223> OTHER INFORMATION: Pinus radiata MADS box protein mRNA, complete 
cds
<300> PUBLICATION INFORMATION:
<301> AUTHORS: Jun-Jun, Liu 
Podila, G K.
<302> TITLE: Not applicable 
<303> JOURNAL: Direct submission 
<304> VOLUME: - 
<305> ISSUE: -
<306> PAGES: --
<307> DATE: 1997-09-09
<308> DATABASE ACCESSION NUMBER: Genbank AF023615 
<309> DATABASE ENTRY DATE: 1999-01-26 
<313> RELEVANT RESIDUES: 1 TO 909
<400> SEQUENCE: 3
atg ggt cgt ggg aag att gag ata aag agg att gaa aat act acg aac 48
Met Gly Arg Gly Lys lie Glu lie Lys Arg lie Glu Asn Thr Thr Asn
1 5  10 15
cga cag gtc act ttc tgc aag cgc cga aat ggt tta tta aag aag gcg 96
Arg Gin Val Thr Phe Cys Lys Arg Arg Asn Gly Leu Leu Lys Lys Ala
20 25 30
tat gaa tta tea gtt ett tgt gat gca gaa gtg gcc etc ate gtc ttc 144
Tyr Glu Leu Ser Val Leu Cys Asp Ala Glu Val Ala Leu lie Val Phe
35 40 45
tcc age aga ggg aga ett tat gaa ttt gcc aac cac age gtg aag agg 192
Ser Ser Arg Gly Arg Leu Tyr Glu Phe Ala Asn His Ser Val Lys Arg
50 55 60
acg att gag agg tac aag aag act tgc gtt gac aac aac cac gga ggg 240
Thr lie Glu Arg Tyr Lys Lys Thr Cys Val Asp Asn Asn His Gly Gly
65 70 75 80
gcg ata tea gag tcc aat tet cag tat tgg caa cag gag get ggt aaa 288
Ala lie Ser Glu Ser Asn Ser Gin Tyr Trp Gin Gin Glu Ala Gly Lys
85 90 95
etc aga caa cag att gac att ttg caa aat gca aat agg cat ttg atg 336
Leu Arg Gin Gin lie Asp lie Leu Gin Asn Ala Asn Arg His Leu Met
100 105 110
ggt gac ggg ett aca get ttg aac att aag gaa etc aag caa ett gag 384
Gly Asp Gly Leu Thr Ala Leu Asn lie Lys Glu Leu Lys Gin Leu Glu
115 120 125
gtt cga ett gaa aaa gga ate age cga gtg cga tcc aaa aag aac gag 432
Val Arg Leu Glu Lys Gly lie Ser Arg Val Arg Ser Lys Lys Asn Glu
130 135 140
atg ttg ett gaa gag ate gac ate atg cag aga agg gaa cac ata ett 480
Met Leu Leu Glu Glu lie Asp lie Met Gin Arg Arg Glu His lie Leu
145 150 155 160
ate cag gag aat gag att ett cgc age aag ata gcc gag tgt cag aat 528
lie Gin Glu Asn Glu lie Leu Arg Ser Lys lie Ala Glu Cys Gin Asn
165 170 175
age cac aac acg aac atg tta tea get ccg gaa tat gat gca ctg ccc 576
Ser His Asn Thr Asn Met Leu Ser Ala Pro Glu Tyr Asp Ala Leu Pro
180 185 190
gca ttc gac tet cga aat ttc eta cat gca aat eta ate gat gcg gcc 624
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Ala Phe Asp Ser Arg Asn Phe Leu His Ala Asn Leu lie Asp Ala Ala 
195 200 205
cat cac tat gca cat cag gaa caa aca acg ctt cag ctt ggc tga 669
His His Tyr Ala His Gin Glu Gin Thr Thr Leu Gin Leu Gly
210 215 220
acgttgaagc ggtggacgct taaaactcaa tcaaggcacc cgaaaaatat gctagtaacc 729
ttgaatgaga ttcagagtcg aaatattgcg aggcaagagc acaatggaag agatagctcc 789
tagtatgaat atggatttat gatattaaca tatggtttgt cagctttaaa tatagctgtt 849
tgaaacaaag aatacaacat attagctagt atttttttgg cgcatgttat ctttctgttg 909
<210> SEQ ID NO 4
<211> LENGTH: 222
<212> TYPE: PRT
<213> ORGANISM: Pinus radiata
<400> SEQUENCE: 4
Met Gly Arg Gly Lys lie Glu lie Lys Arg lie Glu Asn Thr Thr Asn
1 5 10 15
Arg Gin Val Thr Phe Cys Lys Arg Arg Asn Gly Leu Leu Lys Lys Ala
20 25 30
Tyr Glu Leu Ser Val Leu Cys Asp Ala Glu Val Ala Leu lie Val Phe
35 40 45
Ser Ser Arg Gly Arg Leu Tyr Glu Phe Ala Asn His Ser Val Lys Arg
50 55 60
Thr lie Glu Arg Tyr Lys Lys Thr Cys Val Asp Asn Asn His Gly Gly
65 70 75 80
Ala lie Ser Glu Ser Asn Ser Gin Tyr Trp Gin Gin Glu Ala Gly Lys
85 90 95
Leu Arg Gin Gin lie Asp lie Leu Gin Asn Ala Asn Arg His Leu Met
100 105 110
Gly Asp Gly Leu Thr Ala Leu Asn lie Lys Glu Leu Lys Gin Leu Glu
115 120 125
Val Arg Leu Glu Lys Gly lie Ser Arg Val Arg Ser Lys Lys Asn Glu
130 135 140
Met Leu Leu Glu Glu lie Asp lie Met Gin Arg Arg Glu His lie Leu
145 150 155 160
lie Gin Glu Asn Glu lie Leu Arg Ser Lys lie Ala Glu Cys Gin Asn
165 170 175
Ser His Asn Thr Asn Met Leu Ser Ala Pro Glu Tyr Asp Ala Leu Pro
180 185 190
Ala Phe Asp Ser Arg Asn Phe Leu His Ala Asn Leu lie Asp Ala Ala
195 200 205
His His Tyr Ala His Gin Glu Gin Thr Thr Leu Gin Leu Gly
210 215 220
<210> SEQ ID NO 5 
<211> LENGTH: 1012 
<212> TYPE: DNA
<213> ORGANISM: Arabidopsis thaliana 
<220> FEATURE:
<221> NAME/KEY: CDS 
<222> LOCATION: ( 16 )..(795)
<223> OTHER INFORMATION: Arabidopsis thaliana ribonuclease (RNS2) mRNA, 
complete cds
<300> PUBLICATION INFORMATION:
<301> AUTHORS: Taylor, C B.
Bariola, P A. 
delCardayre, S B.
21
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Raines, R T.
Green, P J.
<302> TITLE: RNS2 : a senescence-associated RNase of Arabidopsis that 
diverged from the S-RNases before speciation 
<303> JOURNAL: Proc. Natl. Acad. Sci. U.S.A.
<304> VOLUME: 90 
<305> ISSUE: 11 
<306> PAGES: 5118-5122 
<307> DATE: 1993
<308> DATABASE ACCESSION NUMBER: Genbank 
<309> DATABASE ENTRY DATE: 1994-10-30 
<313> RELEVANT RESIDUES: 1 TO 1012
<400> SEQUENCE: 5
atcgaattaa agtca atg gcg tea cgt tta tgt ett etc ett etc gtt geg 51
Met Ala Ser Arg Leu Cys Leu Leu Leu Leu Val Ala 
1 5  10
tgt ate gee gga gca ttt gcc gga gac gtc ate gaa etc aat ega tet 99
Cys lie Ala Gly Ala Phe Ala Gly Asp Val lie Glu Leu Asn Arg Ser
15 20 25
cag agg gag ttc gat tat ttc get eta tet ett caa tgg cct gga acc 147
Gin Arg Glu Phe Asp Tyr Phe Ala Leu Ser Leu Gin Trp Pro Gly Thr
30 35 40
tat tgc cgt gga act ege cat tgt tgc tcc aaa aac get tgc tgc aga 195
Tyr Cys Arg Gly Thr Arg His Cys Cys Ser Lys Asn Ala Cys Cys Arg
45 50 55 60
ggc tec gat get cca act caa ttc aca att cat ggg tta tgg cct gac 243
Gly Ser Asp Ala Pro Thr Gin Phe Thr lie His Gly Leu Trp Pro Asp
65 70 75
tat aac gat ggt teg tgg cct tea tgt tgt tat ega tet gac ttt aaa 291
Tyr Asn Asp Gly Ser Trp Pro Ser Cys Cys Tyr Arg Ser Asp Phe Lys
80 85 90
gag aag gag att tea aeg ttg atg gat ggt ett gag aag tac tgg cct 339
Glu Lys Glu lie Ser Thr Leu Met Asp Gly Leu Glu Lys Tyr Trp Pro
95 100 105
agt etc agt tgt ggt tet cca tea tea tgc aat ggt ggg aaa ggg tea 387
Ser Leu Ser Cys Gly Ser Pro Ser Ser Cys Asn Gly Gly Lys Gly Ser
110 115 120
ttt tgg ggc cac gag tgg gag aaa cat ggg act tgt tet tet cct gtt 435
Phe Trp Gly His Glu Trp Glu Lys His Gly Thr Cys Ser Ser Pro Val
125 130 135 140
ttt cat gat gag tat aat tac ttc ett acc aca ett aat etc tac ttg 483
Phe His Asp Glu Tyr Asn Tyr Phe Leu Thr Thr Leu Asn Leu Tyr Leu
145 150 155
aag cat aat gtc aeg gat gtc ett tat caa get ggc tat gtt get tcc 531
Lys His Asn Val Thr Asp Val Leu Tyr Gin Ala Gly Tyr Val Ala Ser
160 165 170
aac agt gaa aag tat cct eta gga ggt ate gta aca gcc att cag aat 579
Asn Ser Glu Lys Tyr Pro Leu Gly Gly lie Val Thr Ala lie Gin Asn
175 180 185
gca ttt cat ate ace cct gaa gtg gtt tgc aaa aga gat gca ate gat 627
Ala Phe His lie Thr Pro Glu Val Val Cys Lys Arg Asp Ala lie Asp
190 195 200
gaa ata cgt ata tgc ttc tat aaa gat ttt aag ccc agg gac tgt gtt 675
Glu lie Arg lie Cys Phe Tyr Lys Asp Phe Lys Pro Arg Asp Cys Val
205 210 215 220
ggt tea caa gat ttg aca tet aga aag tea tgc ccc aag tac gta agt 723
Gly Ser Gin Asp Leu Thr Ser Arg Lys Ser Cys Pro Lys Tyr Val Ser
225 230 235
ttg ccg gaa tac aeg cca tta gat ggt gaa get atg gtt ctg aag atg 1 1 1
Leu Pro Glu Tyr Thr Pro Leu Asp Gly Glu Ala Met Val Leu Lys Met
240 245 250
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cca aca gaa aga gaa get ett tga atcggaaaag atgggagctt tgttatcttc 825
Pro Thr Glu Arg Glu Ala Leu 
255
tgagagacaa tacatacatg tctctgatgt tgtaacttta ctaccaaaac ctataaagat 885
tggcttattt cgttctattg gatatgtatc atcattactg gtaaatcaag tttctttcta 945
ataatgtaga agatcagaaa atccataaga agatatcaac atttgagttc tatggtaaaa 1005
aaaaaaa 1012
<210> SEQ ID NO 6 
<211> LENGTH: 259 
<212> TYPE: PRT
<213> ORGANISM: Arabidopsis thaliana 
<400> SEQUENCE: 6
Met Ala Ser Arg Leu Cys Leu Leu Leu Leu Val Ala Cys lie Ala Gly
1 5 10 15
Ala Phe Ala Gly Asp Val lie Glu Leu Asn Arg Ser Gin Arg Glu Phe
20 25 30
Asp Tyr Phe Ala Leu Ser Leu Gin Trp Pro Gly Thr Tyr Cys Arg Gly
35 40 45
Thr Arg His Cys Cys Ser Lys Asn Ala Cys Cys Arg Gly Ser Asp Ala
50 55 60
Pro Thr Gin Phe Thr lie His Gly Leu Trp Pro Asp Tyr Asn Asp Gly
65 70 75 80
Ser Trp Pro Ser Cys Cys Tyr Arg Ser Asp Phe Lys Glu Lys Glu lie
85 90 95
Ser Thr Leu Met Asp Gly Leu Glu Lys Tyr Trp Pro Ser Leu Ser Cys
100 105 110
Gly Ser Pro Ser Ser Cys Asn Gly Gly Lys Gly Ser Phe Trp Gly His
115 120 125
Glu Trp Glu Lys His Gly Thr Cys Ser Ser Pro Val Phe His Asp Glu
130 135 140
Tyr Asn Tyr Phe Leu Thr Thr Leu Asn Leu Tyr Leu Lys His Asn Val
145 150 155 160
Thr Asp Val Leu Tyr Gin Ala Gly Tyr Val Ala Ser Asn Ser Glu Lys
165 170 175
Tyr Pro Leu Gly Gly lie Val Thr Ala lie Gin Asn Ala Phe His lie
180 185 190
Thr Pro Glu Val Val Cys Lys Arg Asp Ala lie Asp Glu lie Arg lie
195 200 205
Cys Phe Tyr Lys Asp Phe Lys Pro Arg Asp Cys Val Gly Ser Gin Asp
210 215 220
Leu Thr Ser Arg Lys Ser Cys Pro Lys Tyr Val Ser Leu Pro Glu Tyr
225 230 235 240
Thr Pro Leu Asp Gly Glu Ala Met Val Leu Lys Met Pro Thr Glu Arg
245 250 255
Glu Ala Leu
<210> SEQ ID NO 7 
<211> LENGTH: 20 
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence 
<220> FEATURE:
<223> OTHER INFORMATION: Description of Artificial Sequence:Made in lab 
<220> FEATURE:
<221> NAME/KEY: modified_base
25
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<222> LOCATION: ( 3 )
<223> OTHER INFORMATION : n=i
<220> FEATURE:
A to V NAME/KEY: modified._base
<222> LOCATION: ( 6 )
<223> OTHER INFORMATION : n=i
<220> FEATURE:
A to V NAME/KEY: modified._base
<222> LOCATION: ( 9 )
<223> OTHER INFORMATION : n=i
<220> FEATURE:
A to to V NAME/KEY: modified._base
<222> LOCATION: ( 1 2 )
<223> OTHER INFORMATION : n=i
<220> FEATURE:
A to V NAME/KEY: modified._base
<222> LOCATION: ( 1 5 )
<223> OTHER INFORMATION : n=i
AooV SEQUENCE: 7
gcngtnagny cntcncccat 20
<210> SEQ ID NO 8 
<211> LENGTH: 17 
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence 
<220> FEATURE:
<223> OTHER INFORMATION: Description of Artificial Sequence:Made in lab 
<220> FEATURE:
<221> NAME/KEY: modified_base 
<222> LOCATION: (6)
<223> OTHER INFORMATION: n=i 
<220> FEATURE:
<221> NAME/KEY: modified_base 
<222> LOCATION: (12)
<223> OTHER INFORMATION: n=i 
<220> FEATURE:
<221> NAME/KEY: modified_base 
<222> LOCATION: (15)
<223> OTHER INFORMATION: n=i
<400> SEQUENCE: 8
aaycgncarg tnacntt 17
<210> SEQ ID NO 9 
<211> LENGTH: 30 
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence 
<220> FEATURE:
<223> OTHER INFORMATION: Description of Artificial Sequence:Made in lab 
<400> SEQUENCE: 9
cgccttcttc aataaaccat ttcggcgctt 30
<210> SEQ ID NO 10 
<211> LENGTH: 30 
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence 
<220> FEATURE:
<223> OTHER INFORMATION: Description of Artificial Sequence:Made in lab 
<400> SEQUENCE: 10
gacctgtcgg ttcgtagtat tttcaatcct 30
<210> SEQ ID NO 11 
<211> LENGTH: 30 
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence 
<220> FEATURE:
<223> OTHER INFORMATION: Description of Artificial Sequence:Made in lab
US 6,858,776 B1
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AOOV SEQUENCE: 11
ttcgtcctcc attttgtgcg ctctccattc 30
<2 10>
<2 11> 
<2 12> 
<2 13> 
<220> 
<223>
SEQ ID NO 12 
LENGTH: 30 
TYPE: DNA
ORGANISM: Artificial Sequence 
FEATURE:
OTHER INFORMATION: Description of Artificial Sequence:Made in lab
AooV SEQUENCE: 12
gcactccact cttcctttat ttcttaccac 30
<2 10>
<2 11> 
<2 12> 
<2 13> 
<220> 
<223>
SEQ ID NO 13 
LENGTH: 27 
TYPE: DNA
ORGANISM: Artificial Sequence 
FEATURE:
OTHER INFORMATION: Description of Artificial Sequence:Made in lab
AooV SEQUENCE: 13
agttacttaa caatgcgcaa ccaaggc 27
A I'd O V SEQ ID NO 14
<2 11> LENGTH: 18
<2 12> TYPE: DNA
<2 13> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Description of Artificial Sequence:Made in lab
AooV SEQUENCE: 14
ttgtgtacaa atcatggg 18
A I'd O V SEQ ID NO 15
<2 11> LENGTH: 18
<2 12> TYPE: DNA
<2 13> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Description of Artificial Sequence:Made in lab
AooV SEQUENCE: 15
gtaagcccgt cacccatc 18
A I'd O V SEQ ID NO 16
<2 11> LENGTH: 20
<2 12> TYPE: DNA
<2 13> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Description of Artificial Sequence:Made in lab
AooV SEQUENCE: 16
gaacaagatg gattgcacgc 20
A I'd O V SEQ ID NO 17
<2 11> LENGTH: 20
<2 12> TYPE: DNA
<2 13> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Description of Artificial Sequence:Made in lab
AooV SEQUENCE: 17
gaagaactcg tcaagaaggc 20
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What is claimed is:
1. An isolated polynucleotide which has the nucleotide 
sequence of SEQ ID NO. 1 and which has the ability, when 
operably associated with a further nucleotide sequence 
encoding a peptide, to promote transcription of said further 
nucleotide sequence, or an isolated polynucleotide which 
has at least 95% nucleotide sequence identity to SEQ ID 
NO. 1 and which is a functionally equivalent variant of SEQ 
ID NO. 1.
2. An isolated plant reproductive tissue specific promoter 
which has the nucleotide sequence of SEQ ID NO. 1 or a 
functionally equivalent variant thereof which has at least 
95% nucleotide sequence identity with SEQ ID NO. 1.
3. An isolated plant reproductive tissue promoter which 
has the nucleotide sequence of SEQ ID NO. 2.
4. A DNA construct which comprises as operably linked 
components:
(a) a polynucleotide having activity as a transcriptional 
promoter according to claim 1;
(b) an open reading frame polynucleotide coding for a 
peptide; and
(c) a termination sequence.
5. A DNA construct which comprises as operably linked 
components:
(a) a promoter sequence as given in SEQ ID NO. 1 or a 
functionally equivalent variant thereof which has at 
least 95% homology to SEQ ID NO. 1 or a promoter 
sequence as given in SEQ ID NO. 2;
(b) an open reading frame polynucleotide coding for a 
peptide; and
(c) a termination sequence.
6. The construct as claimed in claim 4 or claim 5 in which 
the open reading frame is in a sense orientation.
7. The construct as claimed in claim 4 or claim 5 in which 
the open reading frame is in an anti-sense orientation.
8. The construct according to claim 5 wherein said open 
reading frame encodes a peptide having SEQ ID NO. 4.
9. The construct according to claim 6 wherein said open 
reading frame polynucleotide encodes a peptide which, 
when expressed in reproductive tissue of a plant, causes said 
plant’s reproductive organs to abort.
10. The construct according to claim 6 wherein said open 
reading frame polynucleotide encodes a peptide which, 
when expressed in reproductive tissue of a plant, causes said 
plant’s reproductive organs to redefine themselves as veg­
etative.
11. The construct according to claim 6 wherein said open 
reading frame polynucleotide encodes a peptide which, 
when expressed in reproductive tissue of a plant, causes said 
plant’s reproductive organs to stop development.
12. The construct according to claim 6 wherein said open 
reading frame polynucleotide encodes a peptide which, 
when expressed in reproductive tissue of a plant, causes cell 
death.
13. The construct according to claim 12 wherein the 
peptide which causes cell death is selected from the group 
consisting of diphtheria toxin A and Barnase.
14. The construct according to claim 12 wherein the 
peptide which causes cell death is an RNAse.
15. The construct according to claim 14 wherein said 
RNase is encoded by the nucleotide sequence of SEQ ID 
NO. 5.
16. The construct according to claim 6 wherein said open 
reading frame polynucleotide encodes a peptide which, 
when expressed in reproductive tissue of a plant, causes an 
alteration in the timing of flowering of said plant.
17. The construct according to claim 5 which further 
includes:
(d) a selection marker sequence.
18. The construct according to claim 17 in which said 
selection marker sequence is the NPTII gene.
19. A transgenic plant cell which includes a construct 
according to claim 5.
20. A transgenic plant which includes a construct accord­
ing to claim 8 .
21. A transgenic plant which contains a polynucleotide 
according to claim 1 or a promoter according to claim 5, 
which plant has a reduced reproductive capacity.
22. The transgenic plant according to claim 21 wherein in 
said plant said polynucleotide or said promoter is opera­
tively associated with a nucleotide sequence encoding a 
peptide, which when expressed in reproductive tissue of the 
plant, causes the plant’s reproductive organs to abort, rede­
fine as vegetative or stop development.
23. The transgenic plant according to claim 21 wherein in 
said plant said polynucleotide or promoter is operatively 
associated with a nucleotide sequence encoding a RNAse.
24. The transgenic plant according to claim 23 in which 
the RNAse has the sequence of SEQ ID NO. 6.
25. The transgenic plant according to claim 20 wherein 
said plant is a coniferous plant.
26. The transgenic plant according to claim 25 which is a 
coniferous plant of the Firms genus.
27. The transgenic plant according to claim 26 which is a 
member of a species selected from the group consisting of 
Firms radiata, Firms taeda, Firms elliotti, Firms clausa, 
Firms palustrus, Firms echinata, Firms ponderosa, Firms 
Jeffrey, Firms resinosa, Firms rigida, Firms banksiana, Firms 
serotina, Firms strobus, Firms m onticola, Firms 
lambertiana, Firms virginiana, Firms contorta, Firms 
cariboea, Firms pinaster, Pinus brutia, Pinus eldarica, 
Pinus coulteri, Pinus nigra, Pinus sylvestris, Pinus 
tecunumannii, Pinus keysia, Pinus oocarpa and Pinus maxi- 
numoii; and hybrids between any of the above species.
28. The transgenic plant according to claim 20 wherein 
said plant is a tree.
29. The transgenic plant according to claim 28 which is a 
member of the Eucalyptus genus.
30. The transgenic plant according to claim 26 which is a 
member of a species selected from the group consisting of 
Eucalyptus alba, Eucalyptus bancroftii, Eucalyptus 
botyroides, Eucalyptus bridgesiana, Eucalyptus calophylla, 
Eucalyptus camaldulensis, Eucalyptus citriodora, Eucalyp­
tus cladocalyx, Eucalyptus coccifera, Eucalyptus curtisii, 
Eucalyptus dalrympleana, Eucalyptus deglupta, Eucalyptus 
delagatensis, Eucalyptus diversicolor, Eucalyptus dunnii, 
Eucalyptus ficifolia, Eucalyptus globulus, Eucalyptus 
gomphocephala, Eucalyptus gunnii, Eucalyptus henryi, 
Eucalyptus laevopinea, Eucalyptus macarthurii, Eucalyptus 
m acrorhyncha, E uca lyp tus m aculata, E uca lyp tus  
marginata, Eucalyptus megacarpa, Eucalyptus melliodora, 
Eucalyptus nicholii, Eucalyptus nitens, Eucalyptus nova- 
anglica, Eucalyptus obliqua, Eucalyptus obtusiflora, Euca­
lyptus oreades, Eucalyptus pauciflora, Eucalyptus 
polybractea, Eucalyptus regnans, Eucalyptus resinifera, 
Eucalyptus robusta, Eucalyptus rudis, Eucalyptus saligna, 
Eucalyptus sideroxylon, Eucalyptus stuartiana, Eucalyptus 
tereticornis, Eucalyptus torelliana, Eucalyptus urnigera, 
Eucalyptus urophylla, Eucalyptus viminalis, Eucalyptus 
viridis, Eucalyptus wandoo and Eucalyptus youmanni; and 
hybrids between any of the above species.
30
5
10
15
20
25
30
35
40
45
50
55
60
65
UNITED STATES PATENT AND TRADEM ARK OFFICE
CERTIFICATE OF CORRECTION
PATENT NO. : 6,858,776 B1 
DATED : February 22, 2005
Page 1 of 1
INVENTOR(S) : Podila et al.
It is certified that error appears in the above-identified patent and that said Letters Patent is 
hereby corrected as shown below:
Column 2,
Line 33, delete "cause, " and replace with -  clausa 
Column 9,
Line 53, delete "2,&I" and replace with -  2 pi 
Column 10,
Line 4, delete "5a" and replace with -  5'
Line 6, delete "COT" and replace with -  CGT 
Line 51, delete "GAP2" and replace with -  GSP2
Column 11,
Line 28, delete "80° C." and replace with -  -80° C.
Line 31, delete "Hin III" and replace with -  Hind III
Column 12,
Line 9, delete "f" and replace with -  of
Line 21, delete "ethod" and replace with -  method
Line 40, delete "GAT GCA" and replace with -  GAT GGA
Column 30,
Line 43, delete "claim 26 "  and replace with -  claim 29
Signed and Sealed this
Thirtieth Day of August, 2005
JON W. DUD AS
Director o f the United States Patent and Trademark Office
